Sonoma Pharmaceuticals Inc. (SNOA)
NASDAQ · Healthcare
Sonoma Pharmaceuticals Inc. Long Term Debt 2011–2025
Sonoma Pharmaceuticals Inc. annual/quarterly long term debt history from 2011 to 2021. Long term debt refers to financial obligations that are due more than one year in the future.
- Sonoma Pharmaceuticals Inc. long term debt for the quarter ending March 31, 2021 were 1.3M, a 292.22% increase year-over-year.
- Sonoma Pharmaceuticals Inc. long term debt for 2021 were 1.3M, a 292.22% increase from 2019.
- Sonoma Pharmaceuticals Inc. long term debt for 2019 were 334,000, a 27.48% increase from 2018.
- Sonoma Pharmaceuticals Inc. long term debt for 2018 were 262,000, a 52.33% increase from 2017.
- Sonoma Pharmaceuticals Inc. long term debt for 2017 were 172,000.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Sonoma Pharmaceuticals Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2021 | $1 |
| 2019 | $0 |
| 2018 | $0 |
| 2017 | $0 |
| 2014 | $0 |
| 2013 | $3 |
| 2012 | $2 |
| 2011 | $2 |
| Sonoma Pharmaceuticals Inc. Quarterly Long Term Debt (Millions of US $) | |
|---|---|
| 2021-03-31 | $1 |
| 2019-03-31 | $0 |
| 2018-03-31 | $0 |
| 2017-03-31 | $0 |
| 2014-03-31 | $0 |
| 2013-03-31 | $3 |
| 2012-03-31 | $2 |
| 2011-03-31 | $2 |
Sonoma Pharmaceuticals Inc. Long Term Debt — FAQ
Sonoma Pharmaceuticals Inc. (SNOA) long term debt over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see SNOA's long term debt history?
The chart and table above show Sonoma Pharmaceuticals Inc.'s long term debt by year and by quarter, including the growth rate.